Wuhan Healthgen Biotechnology Corp. (SHA:688765)
25.67
-1.60 (-5.87%)
At close: Nov 20, 2026
SHA:688765 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,023 | 669.44 | 160.4 | 235.97 | 387.56 | 243.41 |
Cash & Short-Term Investments | 1,537 | 669.44 | 160.4 | 235.97 | 387.56 | 243.41 |
Cash Growth | 1061.18% | 317.35% | -32.02% | -39.11% | 59.22% | 61.51% |
Accounts Receivable | 0.49 | 0.45 | 0.14 | 0.2 | 0.09 | 0.02 |
Other Receivables | 1 | 1.79 | 0.35 | 0.35 | 0.29 | 0.77 |
Receivables | 1.48 | 2.23 | 0.49 | 0.55 | 0.38 | 0.79 |
Inventory | 242.18 | 119.32 | 50.02 | 35.73 | 25.66 | 12.52 |
Other Current Assets | 100.24 | 1,371 | 26.43 | 16.42 | 34.78 | 26.49 |
Total Current Assets | 1,881 | 2,162 | 237.34 | 288.67 | 448.38 | 283.21 |
Property, Plant & Equipment | 1,864 | 1,264 | 733.42 | 606.23 | 580.78 | 208.24 |
Other Intangible Assets | 83.12 | 84.42 | 87.39 | 66.24 | 68.08 | 24.53 |
Long-Term Deferred Charges | - | 2.94 | 3.56 | 0.07 | - | - |
Other Long-Term Assets | 22.34 | 189.53 | 0.1 | 0.99 | 5.43 | 77.16 |
Total Assets | 3,851 | 3,703 | 1,062 | 962.2 | 1,103 | 593.13 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 62.53 | 370.36 | 175.9 | 105.77 | 169.84 | 122.1 |
Accrued Expenses | 51.08 | 13.19 | 8.78 | 9.56 | 7.88 | 6.05 |
Short-Term Debt | 4 | - | 10.01 | - | - | - |
Current Portion of Long-Term Debt | 13.55 | 47.28 | 7.36 | 1.07 | 1.02 | - |
Current Portion of Leases | 9.91 | 7.78 | 2.27 | 0.29 | 0.55 | 0.37 |
Current Unearned Revenue | 12.93 | 2.57 | 2.45 | 1.87 | 1.14 | 1.1 |
Other Current Liabilities | 473.26 | 12.41 | 25.89 | 2.14 | 10.39 | 2.02 |
Total Current Liabilities | 627.26 | 453.6 | 232.67 | 120.7 | 190.82 | 131.63 |
Long-Term Debt | 263.71 | 243.92 | 184 | 90.12 | 13.13 | - |
Long-Term Leases | 76.89 | 69.35 | 19.29 | 2.45 | 0.54 | 0.39 |
Long-Term Unearned Revenue | 39.01 | 36.65 | 23.02 | 15.83 | 1.43 | 1.79 |
Other Long-Term Liabilities | - | 1.49 | 1.49 | 1.49 | 1.49 | - |
Total Liabilities | 1,007 | 805 | 460.46 | 230.58 | 207.41 | 133.81 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 357.5 | 357.5 | 268.05 | 268.05 | 268.05 | 239.13 |
Additional Paid-In Capital | 3,557 | 3,549 | 1,185 | 1,164 | 1,140 | 589.64 |
Retained Earnings | -1,071 | -1,008 | -851.36 | -699.99 | -513.03 | -369.45 |
Shareholders' Equity | 2,844 | 2,898 | 601.35 | 731.62 | 895.26 | 459.32 |
Total Liabilities & Equity | 3,851 | 3,703 | 1,062 | 962.2 | 1,103 | 593.13 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 368.05 | 368.33 | 222.93 | 93.93 | 15.25 | 0.76 |
Net Cash (Debt) | 1,169 | 301.11 | -62.53 | 142.04 | 372.31 | 242.65 |
Net Cash Growth | - | - | - | -61.85% | 53.44% | 72.47% |
Net Cash Per Share | 3.57 | 1.06 | -0.23 | 0.53 | 1.43 | 1.12 |
Filing Date Shares Outstanding | 357.5 | 357.5 | 268.05 | 268.05 | 261.05 | 268.05 |
Total Common Shares Outstanding | 357.5 | 357.5 | 268.05 | 268.05 | 261.05 | 239.13 |
Working Capital | 1,254 | 1,709 | 4.68 | 167.97 | 257.57 | 151.58 |
Book Value Per Share | 7.95 | 8.11 | 2.24 | 2.73 | 3.43 | 1.92 |
Tangible Book Value | 2,761 | 2,813 | 513.96 | 665.38 | 827.18 | 434.8 |
Tangible Book Value Per Share | 7.72 | 7.87 | 1.92 | 2.48 | 3.17 | 1.82 |
Buildings | 260.46 | 257.07 | 220.85 | - | - | - |
Machinery | 499.88 | 494.74 | 471.75 | - | - | - |
Construction In Progress | 1,218 | 602.79 | 133.75 | - | - | - |